North America Cryptococcosis Market Size & Outlook, 2026-2034


North America Cryptococcosis Market Insights

  • Reed Intelligence analysis indicates that the North America Cryptococcosis Market size, which was USD 262.41 Million in 2025, is projected to attain USD 464.1 Million by 2034.
  • The market is expected to register a CAGR of 6.55% over the period 2026–2034.
  • In 2025, Azoles emerged as the dominant By Drug Class based on market size.
  • Polyenes is projected to register the fastest growth, positioning it as the most attractive By Drug Class segment over the forecast horizon.

Other Key Findings


  • In 2025, North America contributed 38.59% to the overall global Cryptococcosis Market size.
  • By 2034, United States is anticipated to dominate the global market based on market size.
  • United States is expected to witness the fastest growth within North America, attaining USD 374.33 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 262.41 Million
Market Size In 2034 USD 464.1 Million
Largest segment Azoles
Units Revenue in USD Million
CAGR 6.55% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
By Drug Class
  1. Azoles
  2. Polyenes
  3. Flucytosine
  4. Combination Therapy
By Indication
  1. Cryptococcal Meningitis
  2. Pulmonary Cryptococcosis
  3. Disseminated Cryptococcosis
By Route of Administration
  1. Oral
  2. Intravenous
By End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends